Shield Therapeutics PLC Stock
Price
Target price
€0.092
€0.092
-24.590%
-0.03
-24.590%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Shield Therapeutics PLC Stock
Shield Therapeutics PLC took a tumble today and lost -€0.030 (-24.590%).
Pros and Cons of Shield Therapeutics PLC in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Shield Therapeutics PLC vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Shield Therapeutics PLC | -24.590% | -25.203% | 54.622% | 148.649% | 222.807% | 44.882% | -87.895% |
| Card Factory plc | -0.930% | -0.563% | -2.930% | -11.074% | -6.360% | 28.641% | 129.437% |
| Pets At Home Group Ls 1 | -1.540% | -5.122% | -2.912% | -17.351% | -6.039% | -27.516% | -45.314% |
| Natural Grocers By Vit. Cot. | 4.670% | -5.882% | -18.248% | -46.411% | -40.107% | - | - |
News
Why Guardant Health Stock Surged Today
Shares of Guardant Health (NASDAQ: GH) rocketed 28% higher on Thursday after the precision oncology company reported outstanding growth metrics across its key product lines.
Image source: Getty
Guardant Health (GH) Q2 Revenue Up 31%
Guardant Health (NASDAQ:GH), a precision oncology company specializing in advanced cancer diagnostics and screening, reported results for the second quarter of fiscal 2025 on July 30, 2025. The